Game-changing MRI technology: Zynext Ventures bets big on Neuro42’s brain imaging
Zynext Ventures USA LLC, the venture capital arm of Zydus Lifesciences, has made a significant investment in Neuro42 Inc., a US-based company specialising in advanced ... Read More
Nura Bio kicks off Phase 1 clinical trials for SARM1 inhibitor NB-4746
Nura Bio, a leading biopharmaceutical company specializing in neuroprotective, small molecule therapies, announced today the initiation of Phase 1 clinical trials for its groundbreaking SARM1 ... Read More
ATAI Life Sciences partners with Neuronasal to develop concussion treatment
ATAI Life Sciences, a German biotech company focused on developing drugs for mental illnesses, has partnered with Neuronasal to develop a short-term treatment for mild ... Read More